A novel Drosophila model for neurodevelopmental disorders associated with Shwachman-Diamond syndrome

Neurosci Lett. 2020 Nov 20:739:135449. doi: 10.1016/j.neulet.2020.135449. Epub 2020 Oct 25.

Abstract

Genetic defects in ribosome biogenesis result in a group of diseases called ribosomopathies. Patients with ribosomopathies manifest multiorgan phenotypes, including neurological impairments. A well-characterized ribosomopathy, Shwachman-Diamond syndrome (SDS), is mainly associated with loss-of-function mutations in the causal gene SBDS. Children with SDS have neurodevelopmental disorders; however, the neurological consequences of SBDS dysfunction remain poorly defined. In the present study, we investigated the phenotype of Drosophila melanogaster following knockdown of CG8549, the Drosophila ortholog of human SBDS, to provide evidence for the neurological consequences of reduction in physiological SBDS functions. The pan-neuron-specific knockdown of CG8549 was associated with locomotive disabilities, mechanically induced seizures, hyperactivity, learning impairments, and anatomical defects in presynaptic terminals. These results provide the first evidence of a direct link between a reduction in physiological SBDS function and neurological impairments.

Keywords: Drosophila melanogaster; Neurodevelopmental disorders; Ribosomopathy; SBDS; Shwachman-Diamond syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal
  • Disease Models, Animal*
  • Drosophila Proteins / genetics*
  • Drosophila melanogaster
  • Gene Knockdown Techniques
  • Humans
  • Male
  • Neurodevelopmental Disorders / genetics*
  • Neurodevelopmental Disorders / pathology
  • Neurodevelopmental Disorders / psychology
  • Neurons / pathology
  • Proteins / genetics
  • Shwachman-Diamond Syndrome / genetics*
  • Shwachman-Diamond Syndrome / pathology
  • Shwachman-Diamond Syndrome / psychology

Substances

  • Drosophila Proteins
  • Proteins
  • SBDS protein, human